Company intelligence / Profile preview

AION Biosystems

New York City / Darien Court / Manhattan, New York, United Statesaionbiosystems.com ↗

Ownership: Private
Employees: ~11
Development stage: Commercial

Overview

AION Biosystems has developed the AION TempShield™, a wearable medical device that continuously monitors body temperature to enable early infection detection. The system leverages AI and cloud-based analytics to provide predictive insights for clinicians and healthcare systems. The product is used particularly in oncology settings but also serves broader high-risk populations. Clinical results highlight earlier intervention opportunities that can reduce hospitalizations and improve outcomes.

Therapeutic areas: Infectious Diseases
Modalities: DeviceWearable biosensorPredictive analytics platform (AI-driven)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on AION Biosystems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AION Biosystems.

Explore the full profile